Injecting drug users who are (un)aware of their HIV serostatus: findings from the multi-center study AjUDE-Brasil II

• Published in: Cadernos de saúde pública 2006-04, Vol.22 (4), p.815-826
• Main Authors: Ferreira, Aline Dayrell, Caiaffa, Waleska Teixeira, Bastos, Francisco I, Mingoti, Sueli Aparecida
• Format: Article
• Language: English
• Subjects: Acquired Immunodeficiency Syndrome; AIDS Serodiagnosis; Brazil - epidemiology; Cross-Sectional Studies; Educational Status; Enzyme-Linked Immunosorbent Assay; Female; Health Knowledge, Attitudes, Practice; Health Policy & Services; HIV; HIV Infections - diagnosis; HIV Infections - epidemiology; Humans; Interviews as Topic; Intravenous Substance Abuse; Male; Needle-Exchange Programs - statistics & numerical data; Sexual Behavior; Substance Abuse, Intravenous - complications; Substance Abuse, Intravenous - epidemiology
• ISSN: 0102-311X; 1678-4464; 0102-311X; 1678-4464
• DOI: 10.1590/s0102-311x2006000400020

This study aimed to characterize the profiles of injecting drug users (IDUs) who were unaware of their HIV serostatus, given the importance of this information for prevention strategies, especially in this vulnerable population, key to the HIV/AIDS dynamic. As part of a cross-sectional multi-city survey, IDUs were interviewed and HIV-tested by the ELISA technique. IDUs were categorized according to knowledge of their own HIV status as either aware or unaware. Means, averages, and proportions were compared between the groups using bi- and multivariate analyses. Of 857 IDUs interviewed, 34.2% were unaware of their HIV serostatus. Those who were unaware were more likely: to have been recruited at sites where the HIV prevalence rate was considered medium (> 10 to 50%; odds ratio = 8.0) or high (> 50%; 4.0); to be illiterate (OR = 4.54); to have no prior HIV test (OR = 2.22); to be male (OR = 1.81); and to have been enrolled more recently in syringe-exchange programs (OR = 1.69). HIV prevention programs should target both individuals at risk and HIV-positive individuals. Programs to expand access to HIV testing are pivotal and should be tailored to specific contexts and populations.